NCT03031483 2025-01-30
Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed
Clinical Trials
9 trialsNCT04551963 2024-10-26
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
BeiGene
Phase 1 Completed
NCT01516606 2022-08-12
HD-K
IRCCS San Raffaele
Phase 2 Completed
NCT01279252 2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2 Completed
NCT00002682 2018-10-24
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01454076 2017-11-01
Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma
Takeda
Phase 1 Completed
NCT00201422 2016-03-28
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma
National Health Research Institutes, Taiwan
Phase NA Completed
NCT00461084 2014-09-18
Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Memorial Sloan Kettering Cancer Center
Completed
NCT00003151 2012-07-02
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed